Skip to main content

Oncology Practice Management seeks to offer process solutions for all members of the cancer care team—medical, surgical, and radiation oncologists, as well as executives, administrators, and coders/billers.

Featured Articles

Practice Management

Preparing for Change: What 2026 Means for Physician Reimbursement and Care Delivery

As we approach 2026, the landscape of physician reimbursement and care delivery will not be business as usual. Between new legislation, major updates to the Medicare Physician Fee Schedule (PFS), and rapid advances in artificial intelligence (AI) and care technology, healthcare delivery is entering a period of significant transition.
Continue Reading
Financial Advocacy

Oncology Financial Advocacy Services Guidelines: Results of a Delphi Study by the ACCC’s Financial Advocacy Network

This research was presented, in part, as a poster at the 2022 ASCO Quality Care Symposium and online-only as an abstract at the 2023 ASCO Annual Meeting.
Continue Reading
FDA Approvals, News & Updates

FDA Approves Epcoritamab-bysp for Follicular Lymphoma Indications

On November 18, 2025, the FDA approved epcoritamab-bysp (Epkinly) in combination with lenalidomide and rituximab (R2) for relapsed or refractory follicular lymphoma (FL).
Continue Reading

Top Trending Articles

Oncology Financial Advocacy Services Guidelines: Results of a Delphi Study by the ACCC’s Financial Advocacy Network
Oncology-Specialized Urgent Care: Keeping Patients Out of the Emergency Department
Patient Support Services Are Available! Connect Your Patients With Critical Resources

Practice Management

Preparing for Change: What 2026 Means for Physician Reimbursement and Care Delivery
2026 ICD‑10-CM Coding Updates: What You Need to Know
Advancing Careers and Improving Practice Performance in the Hematology Oncology Office: The Benefits of CMOM Certification

Reimbursement

505(b)(2) Drugs: New Chaos for Infusion Centers
Achieving Revenue Cycle Management Mastery
Billing for Navigation Services

Healthcare Policy

Updates to NCCN Guidelines for Multiple Myeloma: Recently Approved First-Line Treatments for Patients With NDMM Eligible and Ineligible for Transplant
Medicaid Expansion Boosted Medicaid Enrollment Among Some Older Older Patients
FDA Updates Mammography Regulations with Breast Density Notification Requirement

Featured Video

The Crossroad of Social Determinants of Health and Inequalities in Hematologic Malignancies

Iman Ahmed, PharmD, BCOP, unpacks the evidence for what’s actually contributing to health inequities in hematologic malignancies, and how providers can mitigate these disparities.
View Video
View More Videos

2025 PSS Guide Spotlight

Supporting Your Patients with Personalized Resources

Each year, the publishers of Oncology Practice Management update this comprehensive guide to sponsored patient support programs in the hope it helps you to guide your patients to the tools and resources that provide access to their prescribed medications.

READ INTRODUCTION

Oncology Guide to Patient Support Services Index

The Guide to Patient Support Services Index can be sorted by Drug or Company to help you quickly access information about programs offered by pharmaceutical companies and novel cancer drugs approved in 2024.

VIEW INDEX

Genmab Patient Support Services

Genmab offers patient support services through its MyNavCare program to assist patients who receive Epkinly and through its Seagen Secure patient assistance program for patients who receive Tivdak.

Read More

Merck Helps/Merck Access Program

Merck Helps offers a full suite of support services, including the Merck Patient Assistance Program, the Merck Access Program, and the Merck Co-pay Assistance Program.

Read More

The 2025 Guide to Patient Support Services

The Guide to Patient Support Services Index can be sorted by Drug or Company to help you quickly access information about programs offered by pharmaceutical companies and novel cancer drugs approved in 2024.

VIEW ALL 2025 PROFILES

FDA Approvals, News, & Updates

FDA Approves Epcoritamab-bysp for Follicular Lymphoma Indications
FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive-Stage Small Cell Lung Cancer
FDA Grants Accelerated Approval to Sevabertinib for Non-Squamous Non–Small Cell Lung Cancer

Upcoming Events

Immunotherapy News
 

Advancing Merkel Cell Carcinoma Treatment With Immunotherapy
Bispecific Antibodies in Oncology: Exploring Urban-Rural Disparities in Access and Utilization
HARMONI-2 Demonstrating "Significant" Improvement in PFS With Ivonescimab Over Pembrolizumab
Back to Top